Sorry, you need to enable JavaScript to visit this website.
Home News
Science

Biologics vs. Biosimilars: Key Differences Explained

With the potential to offer targeted therapies and reduced side-effects, the drive towards biologics is exciting.

biologic_vs_biosimilar_785x440.jpg
Science

Zinc Finger Transcription Factors: The On/Off Switch for Genes Inspired by Frogs

Zinc finger transcription technology could be the on/off switch for mutated genes, opening the door to improved ALS treatment.
Zinc_fingers_Frog_785X440.jpg
Science

Making the COVID-19 Oral Treatment: How 2,000+ Pfizer Team Members Made It Happen

As the potential threat of COVID-19 became clear by early 2020, teams across Pfizer sprang into action. Together, they worked to better understand the novel virus.

Making the COVID-19 Oral Treatment

Experience multimedia stories that give you an exciting view of Pfizer’s initiatives as we pursue breakthroughs that change patients’ lives.

Go Behind the Science

News Type

Keywords

  • All Keywords
October 2022
September 2022

This information is intended for media professionals. To ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists. 

  • 00Phase 1
  • 00Phase 2
  • 00Phase 3
  • 00Registration
  • 00Total

We proudly partner with thousands of study sites and tens of thousands of trial participants around the world. It’s these clinical trials that lead to life-changing medicines.

Go to Pfizer Clinical Trials Site

Incredible things can happen when people come together with one shared goal. The future of medicine is happening at Pfizer, and we’re eager to work alongside inspired and inspirational people who want to improve healthcare around the world.

Explore Our Careers